| 000 | 04898nam a22004333i 4500 | ||
|---|---|---|---|
| 001 | EBC30545989 | ||
| 003 | MiAaPQ | ||
| 005 | 20240724115926.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 240724s2023 xx o ||||0 eng d | ||
| 020 |
_a9781804411360 _q(electronic bk.) |
||
| 020 | _z9781804411353 | ||
| 035 | _a(MiAaPQ)EBC30545989 | ||
| 035 | _a(Au-PeEL)EBL30545989 | ||
| 035 | _a(OCoLC)1379756711 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 | _aRJ560 .R674 2023 | |
| 082 | 0 | _a615.1083 | |
| 100 | 1 | _aRose, Klaus. | |
| 245 | 1 | 0 |
_aAbuse of Minors in Clinical Studies : _bA Worldwide Ethical Challenge for the 21st Century. |
| 250 | _a1st ed. | ||
| 264 | 1 |
_aBradford : _bEthics International Press Limited, _c2023. |
|
| 264 | 4 | _c©2023. | |
| 300 | _a1 online resource (305 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aIntro -- Foreword -- Chapter 1 -- Introduction -- References -- Chapter 2 -- Care of Children in History -- Midwifery, classical academic medicine, and medicine's ancient roots -- Hygiene and prevention of infectious diseases -- Baby & -- infant nutrition -- Child advocacy -- The American Academy of Pediatrics (AAP) and conflicts of interest -- Children's rights and their alleged right to have properly tested medicines -- Conclusions -- References -- Chapter 3 -- What is a Child? -- Conclusion -- References -- Chapter 4 -- Emergence of Pediatric Medicine in the 20th Century -- Surgery -- Cancer and other malignancies -- Vaccines and vaccination -- Rheumatology -- Depression -- Conclusion -- References -- Chapter 5 -- The Thalidomide Disaster Triggers Modern Drug Development -- References -- Chapter 6 -- Children as "Therapeutic Orphans" and Developmental Pharmacology -- No major disasters in pediatric medicine -- Developmental physiology and pharmacology -- Children: a neglected population? -- On-label/ off-label use of drugs in children -- Extrapolation from adults to "children" -- Pediatric exclusivity -- Reality is slowly kicking in, but this is not yet officially recognized -- References -- Chapter 7 -- Questionable Pediatric Studies -- Cancer and malignancies before the 18th birthday -- Malignant melanoma -- Autoimmune arthritis in minors/ juvenile idiopathic arthritis (JIA) -- Epilepsy -- Regulatory territorial demands -- Bizarre conclusions from pointless studies -- Misogynist studies -- Multiple sclerosis -- Further questionable studies -- Conclusions -- References -- Chapter 8 -- The Declaration of Helsinki and Research in Minors -- References -- Chapter 9 -- The International Committee of Medical Journal Editors (ICMJE) -- References -- Chapter 10 -- The Council for International Organizations of Medical Sciences (CIOMS). | |
| 505 | 8 | _aReferences -- Chapter 11 -- Institutional Review Boards (IRBs) and Ethics Committees (ECs) -- References -- Chapter 12 -- Gillick Competence -- References -- Chapter 13 -- New Conflicts of Interest in Medical Research -- References -- Chapter 14 -- Neonatology -- References -- Chapter 15 -- Conclusions and Outlook -- References. | |
| 520 | _aWith the emergence of effective drugs and observed drug toxicities in babies, two mantras emerged: that children are therapeutic orphans, and that children are not small adults. US and EU laws demand pediatric studies as a condition for the approval of new drugs in adults. This is called "Pediatric Drug Development" (PDD). Although apparently reasonable, there are catches. Children are vulnerable at birth, but they grow and become bodily mature with puberty, well before coming of age. Minors are not another species. The 18th birthday, an administrative/ legal limit, does not correspond to a physiological change. Drugs treat the body, not the legal status. PDD results in pointless studies in bodily mature adolescents, and in exaggerated studies in younger minors. An originally well-intentioned concept results in thousands of questionable studies worldwide. This book draws attention to conflicts of interest and ethical dilemmas of PDD and questions its applicability for adolescents and minors that are no longer babies. | ||
| 588 | _aDescription based on publisher supplied metadata and other sources. | ||
| 590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
| 650 | 0 | _aPediatric pharmacology-Handbooks, manuals, etc. | |
| 655 | 4 | _aElectronic books. | |
| 776 | 0 | 8 |
_iPrint version: _aRose, Klaus _tAbuse of Minors in Clinical Studies _dBradford : Ethics International Press Limited,c2023 _z9781804411353 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=30545989 _zClick to View |
| 999 |
_c36115 _d36115 |
||